Subarachnoid Hemorrhage
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The results of western blotting suggested that the expressions of MC1R, phosphorylated-adenosine monophosphate-activated protein kinase (p-AMPK), and phosphorylated-TANK binding kinase 1 (p-TBK1) were increased and reached their peak points at 24 h following SAH.
|
31486022 |
2020 |
Open comedone
|
0.010 |
Biomarker
|
disease |
BEFREE |
The MC1R gene did not seem to play a major role in determining the black head and neck in our crossbred goats.
|
31678151 |
2020 |
Malignant transformation
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Activation of EDNRB compensates for MC1R loss of function, thereby reducing the risk of malignant transformation of these vulnerable melanocytes.
|
31505093 |
2020 |
Melanoma, B16
|
0.010 |
Biomarker
|
disease |
BEFREE |
The MC1R-specific targeting and imaging properties of <sup>203</sup>Pb-DOTA-GGNle-CycMSH<sub>hex</sub> were determined on B16/F1 and B16/F10 murine melanoma cells and in B16/F1 flank melanoma-, B16/F10 flank melanoma-, and B16/F10 pulmonary metastatic melanoma-bearing C57 mice.
|
30763112 |
2019 |
Dermatitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
MC1R antagonist agouti-signaling protein inhibited spontaneous scratching in mice with dermatitis.
|
31220451 |
2019 |
Encephalomyelitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Recently, melanocortin-1 receptor (Mc1r) activation by Nle4-D-Phe7-α-MSH (NDP-MSH) was shown to play a neuroprotective role in an experimental autoimmune encephalomyelitis (EAE) mouse model.
|
31660977 |
2019 |
temporal pain
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
All genotyped (17) MC1R variants were tested for association with heat pain temporal summation and sensitivity.
|
31834199 |
2019 |
Endothelial dysfunction
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
These results indicate that the receptor is constitutively expressed by arterial ECs and provide evidence of a novel homeostatic function for MC1R, whose activation may participate in preventing/healing endothelial dysfunction or denudation in macrovascular arteries.
|
31050282 |
2019 |
metastatic intraocular melanoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal Melanoma.
|
30733316 |
2019 |
Chloasma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The fluorescence intensity in the skin from melasma was higher for MC1R, αMSH at epidermis as at melanocytes (P < 0.05).
|
29846953 |
2018 |
Nephrotic Syndrome
|
0.010 |
Biomarker
|
group |
BEFREE |
Amplification of the Melanocortin-1 Receptor in Nephrotic Syndrome Identifies a Target for Podocyte Cytoskeleton Stabilization.
|
30356069 |
2018 |
Dermatitis, Phototoxic
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
MC1R variants associated with increased melanoma risk promote the production of photosensitizing pheomelanins as opposed to photoprotective eumelanins.
|
29622793 |
2018 |
Nevus, Blue
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Specifically, we identified a positive association between the "R" MC1R variants and visible vessels in nevi [p-value = .033, corrected using the FDR method for multiple comparisons (corrected p-value)], dots and globules in nevi (corrected p-value = .033), nevi with eccentric hyperpigmentation (corrected p-value = .033), a high degree of freckling (adj. p-value = .019), and an associative trend with presence of blue nevi (corrected p-value = .120).
|
28950052 |
2018 |
Metastatic malignant neoplasm to brain
|
0.010 |
Biomarker
|
disease |
BEFREE |
Both B16/F10 and M21 melanoma lesions could be easily imaged by positron emission tomography using <sup>68</sup>Ga-DOTA-GGNle-CycMSH<sub>hex</sub> The first-in-human images of melanoma brain metastases in patients demonstrated the clinical relevance of MC1R as a molecular target for melanoma imaging, highlighting the potential of <sup>68</sup>Ga-DOTA-GGNle-CycMSH<sub>hex</sub> as an MC1R-targeting melanoma imaging probe and underscoring the need to develop MC1R-targeting therapeutic agents for treating patients with metastatic melanoma.
|
30404861 |
2018 |
Systemic Inflammatory Response Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Thus, we hypothesized that MC1R single nucleotide polymorphisms (SNPs) would be associated with increased burn-induced SIRS and increased infectious complications.
|
30278967 |
2018 |
Essential Tremor
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The discrepancies found in this study indicate the variant rs34090186 in the MC1R gene, some variants of which were reported to be related to increased risk of PD and melanoma, may play a risk role in ET, confirming a potential association between ET and PD.
|
30252209 |
2018 |
Inflammatory abnormality of the eye
|
0.010 |
Biomarker
|
disease |
BEFREE |
Preclinical studies were performed to determine whether two MC1r receptor agonists, PL-8177 and PL-8331, exhibit actions and efficacy similar to α-MSH in preventing and reversing intestinal and ocular inflammation.
|
30692924 |
2018 |
Alzheimer's Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.
|
28059796 |
2017 |
Huntington Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that the MC1R gene could modify the AOO in Spanish HD patients and encourage the evaluation of loss-of-function MC1R polymorphisms in other HD populations with a higher frequency of these MC1R polymorphisms.
|
27924526 |
2017 |
Septicemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Therapeutic targeting of MC1R may be beneficial for trauma patients at risk for complicated sepsis.
|
27488084 |
2017 |
Sepsis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Therapeutic targeting of MC1R may be beneficial for trauma patients at risk for complicated sepsis.
|
27488084 |
2017 |
Alzheimer Disease, Late Onset
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We observed that a common MC1R variant p.V92M (rs2228479), not related to pigmentation traits, was present in 72 (14%) patients and 15 (9%) controls and confers increased risk of developing LOAD (OR: 1.99, 95% CI: 1.08-3.64, p = 0.026), especially in those patients whose genetic risk could not be explained by APOE genotype.
|
28059796 |
2017 |
Dyschromatosis universalis hereditaria
|
0.010 |
Biomarker
|
disease |
BEFREE |
Together, our results suggest that a novel SASH1/MAP2K2 crosstalk connects ERK1/2/CREB cascade with p53-POMC-MC1R cascade to cause hyperpigmentation phenotype of DUH.
|
28382689 |
2017 |
Idiopathic Membranous Glomerulonephritis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Four patients with congenital red hair color and nephrotic syndrome caused by idiopathic membranous nephropathy or focal segmental glomerulosclerosis were confirmed by gene sequencing to bear dominant-negative MC1R mutations.
|
27270328 |
2016 |
Orofacial Pain
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
MC1R variants may influence orofacial pain perception and, in turn, predispose individuals to develop fears about pain.
|
27555332 |
2016 |